Hunt K - Search Results

1

Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients.

Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Lee A, et al. Among authors: hunt k. Cancer. 2002 Aug 25;96(4):225-31. doi: 10.1002/cncr.10721. Cancer. 2002. PMID: 12209664 Free article.

2

Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.

Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Hunt KK, et al. Cancer Res. 1997 Nov 1;57(21):4722-6. Cancer Res. 1997. PMID: 9354430

3

Changing trends in the diagnosis and treatment of early breast cancer.

Hunt KK, Ross MI. Hunt KK, et al. Cancer Treat Res. 1997;90:171-201. doi: 10.1007/978-1-4615-6165-1_9. Cancer Treat Res. 1997. PMID: 9367083 Review. No abstract available.

4

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.

Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: hunt kk. Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6. Cancer J Sci Am. 1998. PMID: 9689981 Clinical Trial.

5

Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.

Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ. Hunt KK, et al. Cancer Res. 1998 Dec 15;58(24):5656-61. Cancer Res. 1998. PMID: 9865717

6

Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.

Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: hunt kk. Ann Surg Oncol. 1998 Dec;5(8):673-80. doi: 10.1007/BF02303476. Ann Surg Oncol. 1998. PMID: 9869512

7

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.

Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Pearlstone DB, et al. Among authors: hunt kk. Cancer. 1999 Jan 1;85(1):85-92. doi: 10.1002/(sici)1097-0142(19990101)85:1<85::aid-cncr12>3.0.co;2-a. Cancer. 1999. PMID: 9921978

8

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.

Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: hunt kk. Am J Surg. 1998 Dec;176(6):502-9. doi: 10.1016/s0002-9610(98)00253-0. Am J Surg. 1998. PMID: 9926779 Clinical Trial.

9

Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer.

Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, McNeese MD, Hunt KK. Heaton KM, et al. Among authors: hunt kk. Ann Surg Oncol. 1999 Jan-Feb;6(1):102-8. doi: 10.1007/s10434-999-0102-8. Ann Surg Oncol. 1999. PMID: 10030422

10

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.

Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: hunt kk. J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460. J Clin Oncol. 1999. PMID: 10080586 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,215 results

Search Page

Filters